{"pageContent": "Background: Recurrent prostate cancer after radiotherapy occurs in one in five patients. The efficacy of prostate magnetic resonance imaging (MRI) in recurrent cancer has not been established. Furthermore, high-quality data on new minimally invasive salvage focal ablative treatments are needed.", "metaData": {"source": "Evolution from active surveillance to focal therapy in the management of prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/21675840/"}}